Adenoviral delivery of recombinant DNA into transgenic mice bearing hepatocellular carcinomas

Human Gene Therapy

Volumn 7, Issue 3, 1996, Pages 355-365

  Bao, Jia Ju ^a   Zhang, Wei Wei ^a,b   Kuo, M Tien ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT DNA; VIRUS ENVELOPE PROTEIN; VIRUS T ANTIGEN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEATH; EXPRESSION VECTOR; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEPATITIS B VIRUS; LIVER CANCER; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PORTAL VEIN; REPORTER GENE; SIMIAN VIRUS 40; TOXICITY; TRANSGENE; TUMOR GROWTH; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALIA; HEPATITIS B VIRUS; MUS MUSCULUS; SIMIAE; SIMIAN VIRUS; SIMIAN VIRUS 40;

EID: 0030059402     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.3-355     Document Type: Article

References (35)

1. BONNEKOH, B., GREENHALGH, D.A., BUNDMAN, D.S., ECKHARDT, J.N., LONGLEY, M.A., CHEN, S.H., WOO, S.L., and ROOP, D.R. (1995). Inhibition of melanoma growth by adenoviral-mediated HSV thymidine kinase gene transfer in vivo. J. Invest. Dermat. 104, 313-317.
2. BREEDIS, C., and YOUNG, G. (1954). The blood supply of neoplasms in the liver. Am. J. Pathol. 30, 969-985.
3. CHANG, M.W., BARR, E., SELTZER, J., JIANG, Y.Q., NABEL, G.J., NABEL, E.G., PARMACEK, M.S., and LEIDEN, J.M. (1995). Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of retinoblastoma gene product. Science 267, 518-522.
4. CHEN, S.-H., CHEN, X.H., WANG, Y., KOSAI, K-I., FINEGOLD M.J., RICH, S., and WOO, S.L.C. (1995). Combination gene therapy of liver metastasis of colon carcinoma in vivo. Proc. Natl. Acad. Sci. USA 92, 2573-2581.
5. CHISARI, F.V., KLOPCHIN, K., MORIYAMA, T., PASQUINELLI, C., DUNSFORD, H., SELL, S., PINKERT, C.A., BRINSTER, R.L., and PALMITER, R.D. (1989). Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59, 1145-1156.
6. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
7. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W.-W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
8. DHILLON, A.P., COLOMBARI, R., SAVAGE, K., and SCHEUER, P.J. (1992) An immunohistochemical study of the blood vessels within primary hepatocellular tumors. Liver 12, 311-318.
9. ENGELHARDT, J.F., YE, K., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
10. FANNING, E., and KNIPPERS, R. (1992). Structure and function of simian virus 40 large tumor antigen. Annu. Rev. Biochem. 61, 55-85.
11. GOLDMAN, M.J., YANG, Y., and WILSON, J.M. (1995). Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect. Nature Genet. 9, 126-131.
12. GRAHAM, F.L., and PREVIK, L. (1991). Manipulation of adenovirus vectors. In Methods in Molecular Biology, vol. 7. Gene transfer and expression protocols. E.J. Murray, ed. (The Humana Press Inc., Clifton, NJ) pp. 109-128.
13. HAGSPIEL, K.D., NEIDL, K.F.W., EICHENBERGER, A.C., WEDER, W., and MARINCEK, B. (1995). Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraporative US, and percutaneous US. Radiology 196, 471-478.
14. JAIN, R.K. (1994). Barriers to drug delivery in solid tumors. Sci. Am. 27, 58-65.
15. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.R., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M., and WOO, S.L.C. (1993). In vivo gene therapy of hemophilia B: Sustained partial correction in factor IX-deficient dogs. Science 262, 117-119.
16. KIMURA, O., YAMAGUCHI, Y., GUNNING, K.B., TEETER, L.D., HUSAIN, F., and KUO, M.T. (1994). Retroviral delivery of DNA into the livers of transgenic mice bearing premalignant and malignant hepatocellular carcinomas. Hum. Gene Ther. 5, 845-852.
17. KOZARSKY, K.F., McKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD-PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of low density lipoprotein receptor deficiency in the watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
18. LIU, T.J., ZHANG, W.W., TAYLOR, D.L., GOEPFERT, H., ROTH, J.A., and CLAYMAN, G.L. (1994). Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res. 54, 3662-3667.
19. MACGREGOR, G.R., NOLAN, G.P., FIERING, S., ROEDERER, M., and HERZENBERG, L.A. (1991). Use of E. coli lac Z (β-Galactosidase) as a reporter gene. In Methods in Molecular Biology, Vol. 7. Gene Transfer and Expression Protocols. E.J. Murray, ed. (The Humana Press Inc. Clifton, NJ) pp. 217-235.
20. MUKHOPADHYAY, T., and ROTH, J.A. (1993). A codon 248 p54 mutation retains tumor suppressor function as shown by enhancement of tumor growth by antisense p53. Cancer Res. 53, 4362-4366.
21. O'MALLEY, B.W., JR., CHEN, S.H., SCHWARTZ, M.R., and WOO, S.L. (1995). Adenovirus-mediated gene therapy for human head and neck squamous cell cancer in a nude mouse model. Cancer Res. 55, 1080-1085.
22. ROEMER, K., and FRIEDMANN, T. (1994). Mechanisms of action of the p53 tumor suppressor and prospects for cancer gene therapy by reconstitution of p53 function. Ann. New York Acad. Sci. 716, 265-282.
23. RUSTIGI, V. (1988). Hepatocellular carcinoma. Annu. Rev. Intern. Med. 108, 390-401.
24. SEPULVEDA, A.R., FINEGOLD, M.J., SMITH, B., SLAGLE, B.L., DEMAYO, J.L., SHEN, R., WOO, S.L.C., and BUTEL, J.S. (1989). Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controled by regulation elements of the human a-1-antitypsin gene. Cancer Res. 49, 6109-6117.
25. TANIGUCHI, H., DAIDOH, T., SHICAKI, Y., and TAKAHASHI, T. (1993). Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling. Cancer 71, 50-55.
26. TEETER, L.D., ESTES, M., CHAN, J.Y., ATASSI, H., SELL, S., BECKER, F.F., and KUO, M.T. (1993). Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol. Carcinog. 8, 67-73.
27. TENG, B., BLUMENTHAL, S., FORTE, T., NAVARATNAM, N., SCOTT, J., GOTTO, A M., JR., and CHAN, L. (1994). Adenovirus-mediated gene transfer of rat apolipoprotein B mRNA-editing protein in mice virtually eliminates apolipoprotein B-100 and normal low density lipoprotein production. J. Biol. Chem. 269, 29395-29404.
28. WILLS, K.N., HUANG, W-M., HARRIS, M.P., MACHEMER, T., MANEVAL, D.C., and GREGORY, R.J. (1995) Gene therapy for hepatocellular carcinoma: Chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. Cancer Gene Ther. 3, 191-197.
29. WINTER, T.C., FREENY, P.C., NGHIEM, H.V., MACK, L.A., RATTEN, R.M., THOMAS, C.R., and ELLIOTT, S. (1993). MR imaging with IV superparamagnetic iron oxide: efficiency in the detection of focal hepatic lesion. Am. J. Roentgenol. 161, 1191-1198.
30. YANG, Y., NUNES, F.A., BERENCSI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 262-369.
31. YEI, S., MITTEREDER, N., WERT, S., WHITSETT, J.A., WILMOTT, R.W., and TRAPNELL, B.C. (1994). In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5, 731-744.
32. ZABNER, J., PETERSEN, D.M., PUGA, A.P., GRAHAM, S.M., COUTURE, L.A., KEYES, L.D., LUKASON, M.J., ST. GEORGE, J., A., GREGORY, R.J., SMITH, A.E., and WELCH, M.J. (1994). Safty and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelia of primates and cotton rats. Nature Genet. 6, 75-83.
33. ZHANG, W.-W., FANG, X., BRANCH, C.D., MAZUR, W., FRENCH, B.A., and ROTH, J.A. (1993). Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. BioTechniques 15, 868-872.
34. ZHANG, W.-W., FANG, X., MAZUR, W., FRENCH, B.A., GEORGES, R.N., and ROTH, J.A. (1994). High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther. 1, 5-13.
35. ZHANG, W.W., ALEMANG, R., WANG, J., KOCK, P.E., ORDONEZ, N.B., and ROTH, J.A. (1995) Safty evaluation of Ad5CMV-p53 in vitro and in vivo. Hum. Gene Ther. 6, 155-164.